Lineage Promiscuous Expression of Transcription Factors in Normal Hematopoiesis
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-06-15
著者
-
MIYAMOTO Toshihiro
Center for Cellular and Molecular Medicine, Kyushu University Hospital
-
Akashi Koichi
Center For Cellular And Molecular Medicine Kyushu University Hospital
-
Miyamoto Toshihiro
Center For Cellular And Molecular Medicine Kyushu University Hospital
-
Miyamoto Toshihiro
Center For Cellular And Molecular Medicine Kyushu University Graduate School Of Medical Sciences
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- Reconstitution of HLA-A^*2402-Restricted Cytomegalovirus-Specific T-Cells following Stem Cell Transplantation
- Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
- Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
- Additional acquisition of t(1;21)(p32;q22) in a patient relapsing with acute myelogenous leukemia with NUP98-HOXA9
- Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient
- Epstein-Barr Virus-Positive Blastoid Variant of Mantle Cell Lymphoma in an Adult with Recurrent Infectious Mononucleosis-Like Symptoms : A Case Report
- Lineage Promiscuous Expression of Transcription Factors in Normal Hematopoiesis
- Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
- Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
- Successful Treatment of Primary Cardiac Lymphoma by Rituximab-CHOP and High-Dose Chemotherapy with Autologous Peripheral Blood Stem Cell Transplantation
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
- Late Relapse of Acute Myelogenous Leukemia Followed by Epstein-Barr Virus-Associated Lymphoproliferative Disease 11 Years after Allogeneic Bone Marrow Transplantation
- Origin of Basophils and Mast Cells
- Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma
- Successful Treatment of Diffuse Large B-cell Lymphoma Following Waldenstrom's Macroglobulinemia with CHOP Chemotherapy Followed by Combination Therapy of CHOP with Rituximab
- Influenza-induced Rhabdomyolysis after Autologous Peripheral Blood Stem Cell Transplantation for Malignant Lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Surgical Resection of Malignant Lymphoma in the Right Atrium after Systemic Chemotherapy
- Advances in therapies for acute promyelocytic leukemia
- Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
- Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients